Treatment of psoriasis after initiation of nivolumab therapy for metastatic malignant melanoma: an ancient drug revisited

Gökhan Okan¹, kezban nur pilancı², Cuyan Demirkesen³
¹Private Dermatologist, Istanbul, Turkey
²Department of Oncology, Memorial Bahcelievler Hospital, Istanbul, Turkey
³Department of Pathology, Acibadem University, Istanbul / Turkey

Keywords: checkpoint inhibitors, nivolumab, psoriasis, melanoma, sulfasalazine

Gökhan Okan, kezban nur pilancı, Cuyan Demirkesen. Treatment of psoriasis after initiation of nivolumab therapy for metastatic malignant melanoma: an ancient drug revisited. J Turk Acad Dermatol. 2020; 14(3): 0-0

Sorumlu Yazar: Gökhan Okan, Türkiye

ARAÇLAR

Yazdır

Alıntıyı İndir

RIS

EndNote

BibTex

Medlars

Procite

Reference Manager

E-Postala

Paylaş

Yazara e-posta gönder

Benzer makaleler

PubMed

Google Scholar